The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B)
Abstract
BACKGROUND: Casopitant is a potent and selective NK‐1 receptor antagonist that has shown clinical efficacy in the prevention of chemotherapy‐induced and postoperative‐induced nausea and vomiting. METHODS: In an embryo‐fetal development study, pregnant mice were given vehicle (sterile water) or doses of 30, 100, or 300 mg/kg/day casopitant on Gestation Day (GD) 6 to 15. Fetuses were evaluated for external, visceral, and skeletal abnormalities on GD 18. In a follow‐on study to investigate casopitant‐induced hormonal changes during the developmental period for palate formation, pregnant mice were given vehicle (sterile water) or 300 mg/kg/day casopitant once daily on GD 6 to 13. Blood was collected on GD 13 at various time‐points for measurement of plasma adrenocorticotropic hormone and corticosterone (CRT) concentrations. RESULTS: There was no evidence of developmental toxicity in mice at 30 or 100 mg/kg/day but 9% of fetuses at 300 mg/kg/day had cleft palate. Mice are sensitive to glucocorticoid‐induced cleft palates, and NK‐1 antagonists are known to modulate the hypothalamic–pituitary–adrenal axis leading to increases in corticosterone. On GD 13, mean plasma adrenocorticotropic hormone levels at 300 mg/kg/day were elevated by approximately twofold from vehicle‐treated levels at 1 hr post‐dose and mean plasma CRT levels were elevated by 3, 5, and 10‐fold at 0.5, 1, and 2 hr post‐dose, respectively. CONCLUSIONS: The increased level of CRT was in the range previously shown in the literature to cause cleft palates in mice and was likely the underlying mechanism behind casopitant‐induced cleft palate in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Risk-benefit assessments must consider that, on average, 8 pregnancies at risk for CAH must be treated for every affected female who might benefit from the treatment (443-446).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [446]
Citations
Cites
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer series in statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,608
An Approximate Distribution of Estimates of Variance Components
Satterthwaite, F. E. (1946) · Biometrics Bulletin · doi:10.2307/3002019 · Cited by 4,373
Fleiss, J. L., & Agresti, A. (1991) · Journal of the American Statistical Association · doi:10.2307/2290537 · Cited by 2,641
Practical Non-Parametric Statistics.
Brown, B. M., & Conover, W. J. (1981) · Biometrics · doi:10.2307/2530578 · Cited by 2,412
Nonparametric Statistical Methods
Ramsey, P. H., Hollander, M., & Wolfe, D. A. (2000) · Technometrics · doi:10.2307/1271473 · Cited by 1,167
Neurotransmitter functions of mammalian tachykinins.
Otsuka, M., & Yoshioka, K. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.2.229 · Cited by 1,080
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Park‐Wyllie, L. Y., Mazzotta, P., Pastuszak, A. L., Moretti, M. E., Béïque, L. C., Hunnisett, L., Friesen, M. H., Jacobson, S., Kasapinovic, S., Chang, D., et al. (2000) · Teratology · doi:10.1002/1096-9926(200012)62:6<385::aid-tera5>3.0.co;2-z · Cited by 949
Teratology: Principles and Techniques.
(1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-63-2-355_3 · Cited by 765
Teratogen update: Congenital rubella
Webster, W. S. (1998) · Teratology · doi:10.1002/(sici)1096-9926(199807)58:1<2::aid-tera2>3.0.co;2-4 · Cited by 590
Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate
Wagner, R. L., White, P. F., Kan, P. B., Rosenthal, M. H., & Feldman, D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102202 · Cited by 555
Prenatal Exposure to Prednisone in Humans and Animals Retards Intrauterine Growth
Reinisch, J. M., Simon, N. G., Karow, W. G., & Gandelman, R. J. (1978) · Science · doi:10.1126/science.705336 · Cited by 544
Hayes, R. L., Bennett, G. J., Newlon, P. G., & Mayer, D. J. (1978) · Brain Research · doi:10.1016/0006-8993(78)90306-2 · Cited by 413
Neill, J. D. (1970) · Endocrinology · doi:10.1210/endo-87-6-1192 · Cited by 230
Population-based case-control study of teratogenic potential of corticosteroids
Czeizel, A. E., & Rockenbauer, M. (1997) · Teratology · Cited by 221
Cleft palate: players, pathways, and pursuits
Murray, J. C., & Schutte, B. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422154 · Cited by 191
Potential of Substance P Antagonists as Antiemetics
Diemunsch, P. A., & Gr�lot, L. (2000) · Drugs · doi:10.2165/00003495-200060030-00002 · Cited by 186
Leslie, R. A. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90106-8 · Cited by 174
Teratogenic potential of corticosteroids in humans
Fraser, F. C., & Sajoo, A. (1995) · Teratology · doi:10.1002/tera.1420510107 · Cited by 153
Slotkin, T. A., Saleh, J. L., McCook, E. C., & Seidler, F. J. (1997) · Teratology · doi:10.1002/(sici)1096-9926(199703)55:3<185::aid-tera3>3.0.co;2-1 · Cited by 111
Corticotrope Response to Removal of Releasing Factors and Corticosteroids in Vivo*
Dallman, M. F., Makara, G. B., Roberts, J. L., LEVIN, N., & Blum, M. (1985) · Endocrinology · doi:10.1210/endo-117-5-2190 · Cited by 98
Some aspects of corticosteroid‐induced cleft palate: A review
Greene, R. M., & Kochhar, D. M. (1975) · Teratology · doi:10.1002/tera.1420110106 · Cited by 83
Role of Tachykinins in the Regulation of the Hypothalamo–Pituitary–Adrenal Axis
Nussdorfer, G. G., & Malendowicz, L. K. (1998) · Peptides · doi:10.1016/s0196-9781(98)00017-5 · Cited by 77
Larsen, P. J., Jessop, D. S., Patel, H., Lightman, S. L., & Chowdrey, H. S. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00368.x · Cited by 73
Pattern of Adenohypophyseal Hormone Changes Induced by Various Stressors in Female and Male Rats
Ruisseau, P. D., Tache, Y., Brazeau, P., et al. (2008) · Neuroendocrinology · doi:10.1159/000122818 · Cited by 72
Herrstedt, J., Apornwirat, W., Shaharyar, A., Aziz, Z., Roila, F., Belle, S. V., Russo, M. W., Levin, J., Ranganathan, S., Guckert, M. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8511 · Cited by 71
Chowdrey, H. S., Jessop, D. S., & Lightman, S. L. (2008) · Neuroendocrinology · doi:10.1159/000125544 · Cited by 70
BARLOW, S. M., McElhatton, P. R., & Sullivan, F. (1975) · Teratology · doi:10.1002/tera.1420120202 · Cited by 70
Body Weight in Mouse Embryos Specifies Staging of Tooth Development
PETERKA, M., Lesot, H., & Peterková, R. (2002) · Connective Tissue Research · doi:10.1080/03008200290000673 · Cited by 49
Fabio, R. D., Alvaro, G. S., Griffante, C., Pizzi, D. A., Donati, D., Mattioli, M., Cimarosti, Z., Guercio, G., Marchioro, C., Provera, S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013264 · Cited by 36
Further Evidence for a Role of Arachidonic Acid in Glucocorticoid Teratogenic Action in the Palate
Piddington, R., Herold, R. C. B., & Goldman, A. S. (1983) · Experimental Biology and Medicine · doi:10.3181/00379727-174-41745 · Cited by 29
Minthorn, E. A., Mencken, T., King, A. G., Shu, A., Rominger, D. H., Gontarek, R. R., Han, C., Bambal, R. B., & Davis, C. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021758 · Cited by 25
Effects of betamethasone on the stimulation of corticosterone secretion in rats.
Balfour, D. J. K., & Reid, A. (1979) · PubMed · Cited by 19
Glucocorticoid induction of cleft palate after treatment with titanocene dichloride?
Köpf‐Maier, P. (1985) · Toxicology · doi:10.1016/0300-483x(85)90117-9 · Cited by 17
Miraglia, L., Pagliarusco, S., Bordini, E., Martinucci, S., & Pellegatti, M. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033092 · Cited by 12
Corticosterone induction of cleft palate in mice dosed with orciprenaline sulfate
Iida, H., Kast, A., Tsunenari, Y., & Asakura, M. (1988) · Teratology · doi:10.1002/tera.1420380104 · Cited by 10
Palatal development and the arachidonic acid cascade.
Piddington, R., & Goldman, A. S. (1985) · PubMed · Cited by 9
Casopitant: a new warrior in the antiemetic crusade
Khojasteh, A., Khojasteh, A., Thornburg, B. G., & Maher, K. R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902953746 · Cited by 8
Effects of Anti-Inflammatory Steroids on Mouse Embryonic Movements During Palatal Development
Walker, B. E., & Quarles, J. (1975) · Journal of Dental Research · doi:10.1177/00220345750540061701 · Cited by 8
Pagliarusco, S., Martinucci, S., Bordini, E., Miraglia, L., Cufari, D., Ferrari, L., & Pellegatti, M. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035063 · Cited by 6
Induction of cleft palate in mice after ophthalmic administration of hydrocortisone
Ballard, P. D., Hearney, E. E., & Smith, M. B. (1975) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(75)90042-3 · Cited by 5
Research works printed but not linked: 6
- Conover SJ, 1980, Practical nonparametric statistics, 230
- 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W · DOI
- Harrison S, 2001, Substance P. Int J Biochem Cell Biol, 33, 55
- Salomon DS, 1980, Current research trends in prenatal craniofacial development, 367
- SAS Institute, 1990, SAS/STAT USERS Guide
- Staples RE., 1974, Detection of visceral alterations in mammalian fetuses, Teratology, 9, A37
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Metadata
- Authors
- Ziejewski, M. K., Solomon, H. M., Stanislaus, D., Clark, R. L., White, T. E., & Apostoli, A. R.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Artemis (United States) (US)
- Department of Small Animal Development and Reproductive Toxicology Covance Laboratories, Inc. Vienna Virginia
- Corresponding author
- Ziejewski, Mary K.
- Venue
- Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Publisher
- Wiley
- Published
- 2011-11-29
- Volume
- 95
- Issue
- 1
- Pages
- 54-62
- ISSN
- 1542-9733 (ISSN-L)
- 1542-9741
- OpenAlex
- W1996335987
- Cited by
- 8
- References
- 41
- Citations by year
- 2021: 2 · 2020: 1 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Birth Defects Research Part B Developmental and Reproductive Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Dentistry › Oral Surgery › Cleft Lip and Palate Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- NK1 receptor antagonists, cleft palate, corticosterone, ACTH, embryo-fetal development, developmental toxicity, hypothalamic-pituitary-adrenal axis, prenatal drug exposure, nausea and vomiting prevention
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Cesarean Section, Cleft Palate, Corticosterone, Feeding Behavior, Female, Piperazines, Piperidines, Pregnancy, Urea, Weight Gain, Receptors, Neurokinin-1, Fetal Development, Mice, Neurokinin-1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.